Multifunctional Nanoplatforms for Endoplasmic Reticulum-Targeted Cancer Therapy

Area of Science:

• Oncology
• Nanotechnology
• Cell Biology

Background:

• Cancer treatment innovations focus on targeted drug delivery and therapeutic modalities.
• Organelle-specific delivery, particularly to the endoplasmic reticulum (ER), is a new frontier in cancer therapy.
• The ER is crucial for protein synthesis and cell signaling, making its disruption a viable therapeutic strategy.

Purpose of the Study:

• To review recent advances in ER-targeting nanotherapeutics for cancer treatment.
• To discuss the application of these nanoplatforms in various therapeutic strategies.
• To explore the advantages, challenges, and future clinical translation of ER-targeting precision drugs.

Main Methods:

• Systematic review of recent scientific literature on ER-targeting nanotherapeutics.
• Analysis of nanoplatforms for chemotherapy, phototherapy, immunotherapy, biotherapy, and combination therapy.
• Discussion of mechanistic insights and clinical perspectives.

Main Results:

• ER-targeting nanoplatforms offer improved stability, localization, and drug release compared to traditional drugs.
• Multifunctional nanoplatforms enable precise delivery and enhanced therapeutic effects.
• These nanotherapeutics show potential across diverse cancer treatment modalities.

Conclusions:

• ER-targeting nanotherapeutics represent a significant advancement in precision cancer medicine.
• Further research into advantages, challenges, and mechanisms can accelerate clinical application.
• Nanotechnology-based ER targeting holds promise for overcoming limitations of conventional cancer therapies.